ADVERTISEMENT

EPL Q1 Review - Sequential Margin Recovery; Outlook Positive: Systematix

EPL Q1 Review - Sequential Margin Recovery; Outlook Positive: Systematix

Injector molding process unit to create customized caps and closures  (image: Company website)
Injector molding process unit to create customized caps and closures (image: Company website)

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Systematix Research Report

EPL Ltd.’s Q1 FY22 result was slightly below our estimates with sales/Ebitda/adjusted profit after tax growth of 8%/down 1%/30% YoY.

Revenues were backed by strong growth in Africa, Middle East and South Asia-India (up 29% YoY, organic growth was in high-teens) and America (up 9% YoY).

East Asia and Pacific-China (up 2% YoY) growth was lower while Europe declined (down 10% YoY) on a high base (led by hand sanitizer tubes sales last year) and the Russia plant shutdown in Q4 FY21.

EPL's operating profit margin was 18.1% versus 19.8% YoY and 17.3% QoQ.

Click on the attachment to read the full report:

Systematix EPL Q1FY22 Result Update.pdf

DISCLAIMER

This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.